References
- Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi REM, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1):7–11. doi:https://doi.org/10.1007/s13304-016-0359-y
- Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:https://doi.org/10.1136/gutjnl-2015-310912
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:https://doi.org/10.1002/ijc.31937
- Tournigand C, André T, Bonnetain F, Chibaudel B, Lledo G, Hickish T, Tabernero J, Boni C, Bachet J-B, Teixeira L, et al. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol. 2012;30(27):3353–3360. doi:https://doi.org/10.1200/JCO.2012.42.5645
- Focaccetti C, Bruno A, Magnani E, Bartolini D, Principi E, Dallaglio K, Bucci EO, Finzi G, Sessa F, Noonan DM, et al. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes. PLoS One. 2015;10(2):e0115686. doi:https://doi.org/10.1371/journal.pone.0115686
- Zhang Q-Y, Wang F-X, Jia K-K, Kong L-D. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 2018;9:1253. doi:https://doi.org/10.3389/fphar.2018.01253
- Tiwari A, Saraf S, Verma A, Panda PK, Jain SK. Novel targeting approaches and signaling pathways of colorectal cancer: An insight. World J Gastroenterol. 2018;24(39):4428–4435. doi:https://doi.org/10.3748/wjg.v24.i39.4428
- Katoh Y, Katoh M. Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther. 2005;4(10):1050–1054. doi:https://doi.org/10.4161/cbt.4.10.2184
- Ruiz I ,Altaba A. Gli proteins and Hedgehog signaling: development and cancer. Trends Genet. 1999;15(10):418–425. doi:https://doi.org/10.1016/s0168-9525(99)01840-5
- Yang L, Xie G, Fan Q, Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene. 2010;29(4):469–481. doi:https://doi.org/10.1038/onc.2009.392
- Kim BR, Jeong YA, Na YJ, Park SH, Jo MJ, Kim JL, Jeong S, Lee S-Y, Kim HJ, Oh SC, et al. Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway. Oncotarget. 2017;8(60):101952–101964. doi:https://doi.org/10.18632/oncotarget.21882
- Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz I, Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med. 2009;1(6–7):338–351. doi:https://doi.org/10.1002/emmm.200900039
- Khan I, Yusuf MA, Ansari IA, Akhtar MS. Anticancer potential of andrographolide, a diterpenoid lactone from Andrographis paniculata: a nature’s treasure for chemoprevention and therapeutics. In: Anticancer plants: mechanisms and molecular interactions. Vol. 4. Singapore: Springer; 2018. p. 143–163.
- Khan I, Khan F, Farooqui A, Ansari IA. Andrographolide exhibits anticancer potential against human colon cancer cells by inducing cell cycle arrest and programmed cell death via augmentation of intracellular reactive oxygen species level. Nutr Cancer. 2018;70(5):787–803. doi:https://doi.org/10.1080/01635581.2018.1470649
- Kim TG, Hwi KK, Hung CS. Morphological and biochemical changes of andrographolide-induced cell death in human prostatic adenocarcinoma PC-3 cells. In Vivo. 2005;19:551–557.
- Lindahl E, Azuara C, Koehl P, Delarue M. NOMAD-Ref: visualization, deformation and refinement of macromolecular structures based on all-atom normal mode analysis. Nucleic Acids Res. 2006;34(Web Server issue):W52–W56. doi:https://doi.org/10.1093/nar/gkl082
- Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang T-S, Rivera F, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26(12):2013–2019. doi:https://doi.org/10.1200/JCO.2007.14.9930
- Tol J, Punt CJ. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Clin Ther. 2010;32(3):437–453. doi:https://doi.org/10.1016/j.clinthera.2010.03.012
- Wu T, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev. 2005:Cd004540. doi: https://doi.org/10.1002/14651858.CD004540.pub2.
- Manson MM, Farmer PB, Gescher A, Steward WP. Innovative agents in cancer prevention. Recent Results Cancer Res. 2005;166:257–275. doi:https://doi.org/10.1007/3-540-26980-0_17
- Hossain MS, Urbi Z, Sule A, Hafizur Rahman KM. Andrographis paniculata (Burm. f.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology. ScientificWorldJournal. 2014;2014:274905. doi:https://doi.org/10.1155/2014/274905
- Misra P, Pal NL, Guru PY, Katiyar JC, Srivastava V, Tandon JS. Antimalarial activity of Andrographis paniculata (Kalmegh) against Plasmodium berghei NK 65 in Mastomys natalensis. Int J Pharmacog. 1992;30(4):263–274. doi:https://doi.org/10.3109/13880209209054010
- Harlozinska A. Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Res. 2005;25(5):3327–3333.
- Lee Y-C, Lin H-H, Hsu C-H, Wang C-J, Chiang T-A, Chen J-H. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol. 2010;632(1–3):23–32. doi:https://doi.org/10.1016/j.ejphar.2010.01.009
- Shi M-D, Lin H-H, Chiang T-A, Tsai L-Y, Tsai S-M, Lee Y-C, Chen J-H. Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression. Chem Biol Interact. 2009;180(3):344–352. doi:https://doi.org/10.1016/j.cbi.2009.04.011
- Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK. Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol. 2006;2(9):458–466. doi:https://doi.org/10.1038/nchembio817
- Yeh P, Kishony R. Networks from drug-drug surfaces. Mol Syst Biol. 2007;3:85. doi: doi:https://doi.org/10.1038/msb4100133
- Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P, Goel A. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways. PloS One. 2013;8(2):e57218. doi:https://doi.org/10.1371/journal.pone.0057218
- Shen Y-C, Chen C-F, Chiou W-F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol. 2002;135(2):399–406. doi:https://doi.org/10.1038/sj.bjp.0704493
- Zhou J, Ong CN, Hur GM, Shen HM. Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin. Biochem Pharmacol. 2010;79(9):1242–1250. doi:https://doi.org/10.1016/j.bcp.2009.12.014
- Ahamad MS, Siddiqui S, Jafri A, Ahmad S, Afzal M, Arshad M. Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One. 2014;9(10):e110003. doi:https://doi.org/10.1371/journal.pone.0110003
- Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45(3):528–537. doi:https://doi.org/10.1016/s0008-6363(99)00384-3
- Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148(7):2207–2216.
- Poon IK, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ. 2010;17(3):381–397. doi:https://doi.org/10.1038/cdd.2009.195
- Dartsch DC, Schaefer A, Boldt S, Kolch W, Marquardt H. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. Apoptosis. 2002;7(6):537–548. doi:https://doi.org/10.1023/a:1020647211557
- Khazaei S, Esa NM, Ramachandran V, Hamid RA, Pandurangan AK, Etemad A, Ismail P. In vitro antiproliferative and apoptosis inducing effect of Allium atroviolaceum bulb extract on breast, cervical, and liver cancer cells. Front Pharmacol. 2017;8:5. doi:https://doi.org/10.3389/fphar.2017.00005
- Zhou J, Zhang S, Ong CN, Shen HM. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol. 2006;72(2):132–144. doi:https://doi.org/10.1016/j.bcp.2006.04.019
- O'Brien V, Brown R. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis. 2006;27(4):682–692. doi:https://doi.org/10.1093/carcin/bgi298
- Chao EC, Lipkin SM. Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res. 2006;34(3):840–852. doi:https://doi.org/10.1093/nar/gkj489
- Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG, Levrero M, Wang JY. Jr. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999;399(6738):806–809. doi:https://doi.org/10.1038/21690
- Zabkiewicz J, Clarke AR. DNA damage-induced apoptosis: insights from the mouse. Biochim Biophys Acta. 2004;1705(1):17–25. doi:https://doi.org/10.1016/j.bbcan.2004.09.002
- Müller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest. 2002;20(1):102–109. doi:https://doi.org/10.1081/cnv-120000371
- Liu Y, Bodmer WF. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc Natl Acad Sci USA. 2006;103(4):976–981. doi:https://doi.org/10.1073/pnas.0510146103
- Yang J-L, Qu X-J, Yu Y, Kohn EC, Friedlander ML. Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency. Int J Cancer. 2008;123(2):258–263. doi:https://doi.org/10.1002/ijc.23535
- Jang ER, Ryu M, Park JE, Kim J-H, Lee J-S, Song K. A new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway. J Biol Chem. 2010;285(5):2986–2995. doi:https://doi.org/10.1074/jbc.M109.070466
- Wang J, Wang XF, Zhang LG, Xie SY, Li ZL, Li YJ, Li HH, Jiao F. Involvement of the mitochondrial pathway in p53-independent apoptosis induced by p28GANK knockdown in Hep3B cells. Cytogenet Genome Res. 2009;125(2):87–97. doi:https://doi.org/10.1159/000227831
- Jacob S, Aguado M, Fallik D, Praz F. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res. 2001;61(17):6555–6562.
- Dabiri Y, Abu El Maaty MA, Chan HY, Wölker J, Ott I, Wölfl S, Cheng X. p53-dependent anti-proliferative and pro-apoptotic effects of a gold(I) N-heterocyclic carbene (NHC) complex in colorectal cancer cells. Front Oncol. 2019;9:438. doi:https://doi.org/10.3389/fonc.2019.00438
- Cheung HY, Cheung CS, Kong CK. Determination of bioactive diterpenoids from Andrographis paniculata by micellar electrokinetic chromatography. J Chromatogr A. 2001;930(1–2):171–176. doi:https://doi.org/10.1016/s0021-9673(01)01160-8
- Chen Y-Y, Hsu M-J, Sheu J-R, Lee L-W, Hsieh C-Y. Andrographolide, a novel NF- κ B inhibitor, induces vascular smooth muscle cell apoptosis via a ceramide-p47phox-ROS signaling cascade. Evid Based Complement Alternat Med. 2013;2013:821813. doi: doi:https://doi.org/10.1155/2013/821813
- Sukardiman H, Widyawaruyanti A, Sismindari, Zaini NC. Apoptosis inducing effect of andrographolide on TD-47 human breast cancer cell line. Afr J Trad Complem Altern Med. 2007;4:345–351. doi:https://doi.org/10.4314/ajtcam.v4i3.31228
- Bortner CD, Oldenburg NB, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol. 1995;5(1):21–6. doi:https://doi.org/10.1016/s0962-8924(00)88932-1
- Yang L, Wu D, Luo K, Wu S, Wu P. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Cancer Lett. 2009;276(2):180–188. doi:https://doi.org/10.1016/j.canlet.2008.11.015
- Mytilineou C, Kramer BC, Yabut JA. Glutathione depletion and oxidative stress. Parkinsonism Relat Disord. 2002;8(6):385–387. doi:https://doi.org/10.1016/s1353-8020(02)00018-4
- Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, Marinari UM, Domenicotti C. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013;2013:972913. doi:https://doi.org/10.1155/2013/972913
- Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116(2):205–219. doi:https://doi.org/10.1016/s0092-8674(04)00046-7
- Ozcan Arıcan G, Çakır Ö, Arican E, Turgut-Kara N, Özlem DÖ, Arı S. Effects of Geven root extract on proliferation of HeLa cells and bcl-2 gene expressions. Afr J Biotechnol. 2012;11:4296–4304. doi: https://doi.org/10.5897/AJB11.2971.
- Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342–348. doi:https://doi.org/10.1038/35077213
- Cheung H-Y, Cheung S-H, Li J, Cheung C-S, Lai W-P, Fong W-F, Leung F-M. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med. 2005;71(12):1106–1111. doi:https://doi.org/10.1055/s-2005-873128
- Li J, Cheung HY, Zhang Z, Chan GK, Fong WF. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur J Pharmacol. 2007;568(1–3):31–44. doi:https://doi.org/10.1016/j.ejphar.2007.04.027
- Satyanarayana C, Deevi DS, Rajagopalan R, Srinivas N, Rajagopal S. DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells. BMC Cancer. 2004;4:26. doi:https://doi.org/10.1186/1471-2407-4-26
- Chen S, Chen X, Xiu YL, Sun KX, Zhao Y. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression. Cancer Lett. 2015;362(1):122–130. doi:https://doi.org/10.1016/j.canlet.2015.03.029
- Mir H, Kapur N, Singh R, Sonpavde G, Lillard JW, Singh S. Jr. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors. Cell Cycle. 2016;15(6):819–826. doi:https://doi.org/10.1080/15384101.2016.1148836
- Schneider P, Bayo-Fina JM, Singh R, Kumar Dhanyamraju P, Holz P, Baier A, Fendrich V, Ramaswamy A, Baumeister S, Martinez ED, et al. Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1. Nat Commun. 2015;6:8023. doi:https://doi.org/10.1038/ncomms9023
- Gonnissen A, Isebaert S, Haustermans K. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened. Oncotarget. 2015;6(16):13899–13913. doi:https://doi.org/10.18632/oncotarget.4224
- Tang S-N, Fu J, Nall D, Rodova M, Shankar S, Srivastava RK. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer. 2012;131(1):30–40. doi:https://doi.org/10.1002/ijc.26323
- Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 2002;16(21):2743–2748. doi:https://doi.org/10.1101/gad.1025302